The design basis and application in urology of the tumor-on-a-chip platform

Fei Sheng1, Rui-Peng Jia1

  • 1Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Urologic Oncology
|May 19, 2022
PubMed

Insights

Tumor chips, micro-physiological systems, offer a novel approach to study tumor biology and drug resistance. These advanced platforms show great potential for improving urological cancer treatment and drug development.

Area of Science:

  • Oncology
  • Biotechnology
  • Microfluidics

Background:

  • Clinical research seeks effective tumor treatments due to undefined molecular mechanisms and challenges in drug resistance and screening.
  • Traditional cell and animal models have limitations in accurately replicating the human tumor microenvironment.
  • Novel approaches are essential for advancing cancer therapy and drug development.

Purpose of the Study:

  • To review the design principles and applications of tumor chips in urology oncology.
  • To highlight the potential of micro-physiological systems for studying tumors.
  • To identify challenges and future directions for tumor chip technology.

Main Methods:

  • Review of recent literature on tumor chip technology and its applications.
  • Focus on microfluidic platforms designed to mimic the tumor microenvironment.
  • Analysis of tumor chip utility in urological oncology.

Main Results:

  • Tumor chips effectively replicate key aspects of the human tumor microenvironment.
  • These platforms offer a promising alternative to traditional preclinical models.
  • Applications in urological oncology demonstrate their potential for personalized medicine.

Conclusions:

  • Tumor chips represent a significant advancement in cancer research platforms.
  • They offer a powerful tool for understanding tumor biology and overcoming drug resistance.
  • The technology holds substantial promise for the future treatment and management of urological tumors.

Related Concept Videos